Home

Andrew Hollman Meyer, Chief Business Officer: Janux Therapeutics JANX Sell · Filed 25/05/02

Trade details

Type
Insider sale
Amount
$93,709.35
Shares · price
2,933 sh · $31.95 a share
Held after
82,539 sh
Trade date
25/05/01
Filed
25/05/02
Days to filing
1 days

Sold 3.4% of holdings

Share of holding sold
3.4%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/01~25/05/31

Andrew Hollman Meyer's recent trades

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $28.2K

    Filed 04/13

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $2.6M

    Filed 01/26

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $1.7M

    Filed 01/23

  • Andrew Hollman Meyer

    SellJanux Therapeutics

    $25.8K

    Filed 01/02

  • Andrew Hollman Meyer

    Sell10b5-1 planJanux Therapeutics

    $88.7K

    Filed 25/12/03